[1]
“Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission”, Reumatismo, vol. 75, no. 4, Dec. 2023, doi: 10.4081/reumatismo.2023.1588.